RE: CF to invest more?15 Feb 2024 10:06
CF demonstrating a typical masterclass in malfeasance, he was previously fired from Amyrt as JW & RN were unconvinced of his capability or integrity. Seems eager to take the props away from the CEO of hVIVO also; another acquisition that was not his idea. He appears likeable but not sure what he brings outside of cash.
Credit to him for his ability to self-promote though – the Charles Ponzi of Donegal (he is entertaining!). Sadly, any credible acquirer will be avoiding him like the plague. His network and hVIVO holders may keep the share price artificially high for now but given the increase hires & salaries I’m very interested to see their upcoming annual report. Would be refreshing to see the ‘CFO’ present given that he is drawing a hefty salary to carry CFs laptop. My concern is that without cash to do further clinical trials, they will be a sitting duck and likely be purchased in 12 months for pennies.
The ex-Amryt team appear strong (DA in particular), though the role they played in the company’s success is somewhat misleading based on POLB RNS' (and their lack of Amryt options reflect this).
DA to be CEO in Q2?